Archive | Bachem AG

Home / Archive

50887ISO 13485: The Perfect Fit for Peptide-Based In Vitro Diagnostics

ISO 13485: The Perfect Fit for Peptide-Based In Vitro Diagnostics

Tuesday 2nd November 2021

By Bachem AG Learn More >

50889Thiazine Formation: The Elucidation of a Thiol-Maleimide Side-Reaction

Thiazine Formation: The Elucidation of a Thiol-Maleimide Side-Reaction

Tuesday 2nd November 2021

By Bachem AG Learn More >

50891Luye Pharma – Customer testimonial – Why choose Bachem?

Luye Pharma – Customer testimonial – Why choose Bachem?

Tuesday 2nd November 2021

By Bachem AG Learn More >

50893Bachem capabilities to address the new FDA guideline for synthetic peptides

Bachem capabilities to address the new FDA guideline for synthetic peptides

Tuesday 2nd November 2021

By Bachem AG Learn More >

50907Continuous Chromatography of Peptides

Continuous Chromatography of Peptides

Tuesday 2nd November 2021

By Bachem AG Learn More >

50909Peptide Easy Clean (PEC) as a highly efficient tool for peptide modification

Peptide Easy Clean (PEC) as a highly efficient tool for peptide modification

Tuesday 2nd November 2021

By Bachem AG Learn More >

50911What are oligonucleotides?

What are oligonucleotides?

Tuesday 2nd November 2021

By Bachem AG Learn More >

50913What are peptides?

What are peptides?

Tuesday 2nd November 2021

By Bachem AG Learn More >

ANDA rules clear way for Bachem synthesized Liraglutide

ANDA rules clear way for Bachem synthesized Liraglutide

Thursday 21st October 2021

By Bachem AG Learn More >

50426Bachem active pharmaceutical ingredients

Bachem active pharmaceutical ingredients

Thursday 7th October 2021

By Bachem AG Learn More >

Bachem reports ‘excellent’ first half results for 2021

Bachem reports ‘excellent’ first half results for 2021

Tuesday 21st September 2021

By Bachem AG Learn More >

COVID-19 pandemic highlights Propofol as Bachem success story

COVID-19 pandemic highlights Propofol as Bachem success story

Wednesday 8th September 2021

By Bachem AG Learn More >